BACKGROUND: More than 100 cases of variant CJD resulting from infections with bovine spongiform encephalopathy (BSE) have accumulated in the United Kingdom since 1995. Concern about the possibility of secondary transmissions via blood and blood components donated by infected individuals has prompted a variety of international donor deferral policies that will continue until laboratory and epidemiologic evidence provides a consensus about potential risk. STUDY DESIGN AND METHODS: BSE was passaged through macaque monkeys and then adapted to the prosimian microcebe (Microcebus murinus). Brain homogenate and buffy coat from an affected microcebe were separately inoculated intracerebrally into three healthy microcebes (two animals received brain and one received buffy coat). RESULTS: All three inoculated microcebes became ill after incubation periods of 16 to 18 months. Clinical, histopathologic, and immunocytologic features were similar in each of the recipients. CONCLUSION: Buffy coat from a symptomatic microcebe infected 17 months earlier with BSE contained the infectious agent. This observation represents the first documented transmission of BSE from the blood of an experimentally infected primate, which in view of rodent buffy coat infectivity precedents and the known host range of BSE is neither unexpected nor cause for alarm.
BACKGROUND: More than 100 cases of variant CJD resulting from infections with bovine spongiform encephalopathy (BSE) have accumulated in the United Kingdom since 1995. Concern about the possibility of secondary transmissions via blood and blood components donated by infected individuals has prompted a variety of international donor deferral policies that will continue until laboratory and epidemiologic evidence provides a consensus about potential risk. STUDY DESIGN AND METHODS: BSE was passaged through macaque monkeys and then adapted to the prosimian microcebe (Microcebus murinus). Brain homogenate and buffy coat from an affected microcebe were separately inoculated intracerebrally into three healthy microcebes (two animals received brain and one received buffy coat). RESULTS: All three inoculated microcebes became ill after incubation periods of 16 to 18 months. Clinical, histopathologic, and immunocytologic features were similar in each of the recipients. CONCLUSION: Buffy coat from a symptomatic microcebe infected 17 months earlier with BSE contained the infectious agent. This observation represents the first documented transmission of BSE from the blood of an experimentally infected primate, which in view of rodent buffy coat infectivity precedents and the known host range of BSE is neither unexpected nor cause for alarm.
Authors: Candace K Mathiason; Jeanette Hayes-Klug; Sheila A Hays; Jenny Powers; David A Osborn; Sallie J Dahmes; Karl V Miller; Robert J Warren; Gary L Mason; Glenn C Telling; Alan J Young; Edward A Hoover Journal: J Virol Date: 2010-03-10 Impact factor: 5.103
Authors: Sandra McCutcheon; Anthony Richard Alejo Blanco; E Fiona Houston; Christopher de Wolf; Boon Chin Tan; Antony Smith; Martin H Groschup; Nora Hunter; Valerie S Hornsey; Ian R MacGregor; Christopher V Prowse; Marc Turner; Jean C Manson Journal: PLoS One Date: 2011-08-17 Impact factor: 3.240
Authors: Rocio Castro-Seoane; Holger Hummerich; Trevor Sweeting; M Howard Tattum; Jacqueline M Linehan; Mar Fernandez de Marco; Sebastian Brandner; John Collinge; Peter-Christian Klöhn Journal: PLoS Pathog Date: 2012-02-16 Impact factor: 6.823
Authors: Abigail B Diack; Mark W Head; Sandra McCutcheon; Aileen Boyle; Richard Knight; James W Ironside; Jean C Manson; Robert G Will Journal: Prion Date: 2014-11-01 Impact factor: 3.931
Authors: Vincenzo Mattei; Maria Grazia Barenco; Vincenzo Tasciotti; Tina Garofalo; Agostina Longo; Klaus Boller; Johannes Löwer; Roberta Misasi; Fabio Montrasio; Maurizio Sorice Journal: PLoS One Date: 2009-04-01 Impact factor: 3.240
Authors: Hasier Eraña; Jorge M Charco; Ezequiel González-Miranda; Sandra García-Martínez; Rafael López-Moreno; Miguel A Pérez-Castro; Carlos M Díaz-Domínguez; Adrián García-Salvador; Joaquín Castilla Journal: Biomolecules Date: 2020-03-19